KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $2.2 million.

  • Adaptive Biotechnologies' Interest & Investment Income fell 3592.4% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 3550.23%. This contributed to the annual value of $14.5 million for FY2024, which is 641.94% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Interest & Investment Income stood at $2.2 million, which was down 3592.4% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Interest & Investment Income ranged from a high of $4.6 million in Q4 2023 and a low of $239000.0 during Q4 2021
  • For the 5-year period, Adaptive Biotechnologies' Interest & Investment Income averaged around $2.3 million, with its median value being $2.6 million (2022).
  • Per our database at Business Quant, Adaptive Biotechnologies' Interest & Investment Income tumbled by 7795.44% in 2021 and then skyrocketed by 101586.72% in 2023.
  • Over the past 5 years, Adaptive Biotechnologies' Interest & Investment Income (Quarter) stood at $239000.0 in 2021, then skyrocketed by 988.7% to $2.6 million in 2022, then skyrocketed by 77.29% to $4.6 million in 2023, then plummeted by 33.41% to $3.1 million in 2024, then fell by 27.54% to $2.2 million in 2025.
  • Its last three reported values are $2.2 million in Q3 2025, $2.4 million for Q2 2025, and $2.7 million during Q1 2025.